Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.

In line with the growing prevalence of steatotic disease in the general population, an increasing trend through the years has also been described in the post-LT setting, amounting to 11% for each decade [ 12 , 19 ].

also in 63,971 other papers